Recital 41, Directive (EU) 2001/83

In forcecited 1×

The marketing of medicinal products whose labelling and package leaflets comply with this Directive should not be prohibited or impeded on grounds connected with the labelling or package leaflet.

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    Recitals 2 to 5, 14, 40 and 41 of Directive 2001/83 state: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be attained by …

    17 Nov 2022 · 62020CJ0224